Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 3
2007 1
2008 1
2010 2
2011 1
2012 3
2013 6
2014 22
2015 17
2016 9
2017 3
2018 2
2019 6
2020 12
2021 11
2022 11
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
Güner G, Aktaş BY, Başal FB, Demirkazık A, Gürsoy P, Demirci U, Erman M, Yumuk PF, Şenler FÇ, Çakar B, Çiçin İ, Öztürk A, Coşkun HŞ, Çubukçu E, Işıkdoğan A, Ölmez ÖF, Tatlı AM, Karaağaç M, Şakalar T, Eralp Y, Korkmaz T, Kılıçkap S. Güner G, et al. Among authors: coskun hs. J Cancer Res Clin Oncol. 2023 Nov;149(14):13271-13277. doi: 10.1007/s00432-023-05190-3. Epub 2023 Jul 22. J Cancer Res Clin Oncol. 2023. PMID: 37480524
The importance microRNAs as a biomarker in lung cancer.
Canatan D, Sonmez Y, Yılmaz O, Coşkun HŞ, Göksu SS, Uçar S, Aktekin MR. Canatan D, et al. Among authors: coskun hs. Acta Biomed. 2023 Feb 13;94(1):e2023045. doi: 10.23750/abm.v94i1.13334. Acta Biomed. 2023. PMID: 36786270 Free PMC article.
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group.
Gürbüz M, Kiliçkap S, Bilici A, Karadurmuş N, Sezer A, Şendur MAN, Paydaş S, Artaç M, Fulden Yumuk P, Gürsoy P, Uysal M, Şenol Coşkun H, Tatli AM, Selçukbiricik F, Dişel U, Köksoy EB, Güven DC, Uğrakli M, Akkuş E, Yücel Ş, Erol C, Karakaya S, Şakalar T, Khanmammadov N, Paksoy N, Demirkazik A. Gürbüz M, et al. Among authors: senol coskun h. Medicine (Baltimore). 2022 Dec 16;101(50):e32368. doi: 10.1097/MD.0000000000032368. Medicine (Baltimore). 2022. PMID: 36550824 Free PMC article.
Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.
Yekedüz E, Özbay MF, Çağlayan D, Yıldırım A, Erol C, Yıldırım HÇ, Tunç S, Özyurt N, Özdemir F, Şendur MAN, Işıkdoğan A, Kılıçkap S, Ürün Y, Yalçın Ş, Artaç M, Coşkun HŞ, Utkan G. Yekedüz E, et al. Among authors: coskun hs. Eur J Clin Pharmacol. 2022 Dec;78(12):1973-1979. doi: 10.1007/s00228-022-03403-1. Epub 2022 Oct 21. Eur J Clin Pharmacol. 2022. PMID: 36266366
Use of MicroRNAs as biomarkers in the early diagnosis of prostate cancer.
Canatan D, Yılmaz O, Sonmez Y, Cim A, Baykara M, Savas M, Coskun HS, Goksu SS, Aktekin MR. Canatan D, et al. Among authors: coskun hs. Acta Biomed. 2022 Jul 1;93(3):e2022089. doi: 10.23750/abm.v93i3.11642. Acta Biomed. 2022. PMID: 35775783 Free PMC article.
Development and evaluation of the efficacy of a web-based education program among cancer patients undergoing treatment with systemic chemotherapy: a randomized controlled trial.
Bektas H, Coskun HS, Arikan F, Ozcan K, Tekeli A, Kondak Y, Sezgin MG, Yangec E, Kalav S. Bektas H, et al. Among authors: coskun hs. Support Care Cancer. 2022 Jul;30(7):6021-6033. doi: 10.1007/s00520-022-07039-w. Epub 2022 Apr 12. Support Care Cancer. 2022. PMID: 35412076 Free PMC article. Clinical Trial.
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.
Ilhan Y, Tatli AM, Teker F, Onder AH, Kose F, Geredeli C, Karaagac M, Kaplan MA, Inanc M, Goktas Aydin S, Kargi A, Arak H, Ozturk B, Besen AA, Selvi O, Korkmaz M, Oruc Z, Bozkurt O, Bilici A, Bayram S, Dae SA, Ozdogan M, Coskun HS, Sezgin Goksu S. Ilhan Y, et al. Among authors: coskun hs. Int J Gynecol Cancer. 2022 Apr 4;32(4):502-507. doi: 10.1136/ijgc-2021-003165. Int J Gynecol Cancer. 2022. PMID: 35086927
101 results